First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

NCT02509117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: PF-06751979 single ascending dose
DRUG: Placebo single dose
DRUG: PF-06751979 multiple ascending dose
DRUG: Placebo multiple dose
DRUG: PF-06751979 multiple dose
DRUG: PF-06751979 multiple dose

Sponsor

Pfizer